6:20 PM
Dec 06, 2012
 |  BC Extra  |  Company News

Bayer seeks expanded EU Eylea label

Bayer AG (Xetra:BAYN) submitted an MAA to EMA to expand the label for Eylea aflibercept to include treatment of macular edema following central retinal...

Read the full 109 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >